Literature DB >> 25801566

High prevalence of bla(NDM-1) carbapenemase-encoding gene and 16S rRNA armA methyltransferase gene among Acinetobacter baumannii clinical Isolates in Egypt.

Mohamed Abd El-Gawad El-Sayed-Ahmed1, Magdy Ali Amin2, Wael Mustafa Tawakol3, Lotfi Loucif4, Sofiane Bakour4, Jean-Marc Rolain5.   

Abstract

The main objective of this study was to decipher the molecular mechanism of resistance to carbapenems and aminoglycosides in a large series of 150 Acinetobacter baumannii clinical isolates collected from July 2012 to September 2013 in Egypt. We report for the first time the emergence of bla(NDM-1) and the cooccurrence of 16S rRNA methylase armA with bla(NDM-1) and bla(OXA-23) in Egyptian hospitals. Multilocus sequence typing identified 27 distinct sequence types, 11 of which were novel.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25801566      PMCID： PMC4432156          DOI： 10.1128/AAC.04412-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  CarbAcineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp.

Authors:  Laurent Dortet; Laurent Poirel; Caroline Errera; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

2.  Prevalence of carbapenemase-encoding genes including New Delhi metallo-β-lactamase in Acinetobacter species, Algeria.

Authors:  Esma Mesli; Meryem Berrazeg; Mourad Drissi; Souad Naïma Bekkhoucha; Jean-Marc Rolain
Journal:  Int J Infect Dis       Date:  2013-04-16       Impact factor: 3.623

3.  Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt.

Authors:  Mohamed H Al-Agamy; Noha G Khalaf; Mahmoud M Tawfick; Atef M Shibl; Amany El Kholy
Journal:  Int J Infect Dis       Date:  2014-03-04       Impact factor: 3.623

Review 4.  Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.

Authors:  Marie Kempf; Jean-Marc Rolain
Journal:  Int J Antimicrob Agents       Date:  2011-11-22       Impact factor: 5.283

5.  Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide survey.

Authors:  Luigi Principe; Aurora Piazza; Tommaso Giani; Silvia Bracco; Maria Sofia Caltagirone; Fabio Arena; Elisabetta Nucleo; Federica Tammaro; Gian Maria Rossolini; Laura Pagani; Francesco Luzzaro
Journal:  J Clin Microbiol       Date:  2014-06-11       Impact factor: 5.948

6.  Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt.

Authors:  L Al-Hassan; H El Mehallawy; S G B Amyes
Journal:  Clin Microbiol Infect       Date:  2013-02-15       Impact factor: 8.067

7.  NDM-2 carbapenemase in Acinetobacter baumannii from Egypt.

Authors:  Martin Kaase; Patrice Nordmann; Thomas A Wichelhaus; Sören G Gatermann; Rémy A Bonnin; Laurent Poirel
Journal:  J Antimicrob Chemother       Date:  2011-03-21       Impact factor: 5.790

8.  Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals.

Authors:  Mahmoud Fouad; Ahmed S Attia; Wael M Tawakkol; Abdelgawad M Hashem
Journal:  Int J Infect Dis       Date:  2013-09-11       Impact factor: 3.623

9.  Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79).

Authors:  Thiago Pavoni Gomes Chagas; Karyne Rangel Carvalho; Ivson Cassiano de Oliveira Santos; Ana Paula D'Alincourt Carvalho-Assef; Marise Dutra Asensi
Journal:  Diagn Microbiol Infect Dis       Date:  2014-03-17       Impact factor: 2.803

10.  Epidemiology and clonality of carbapenem-resistant Acinetobacter baumannii from an intensive care unit in Palermo, Italy.

Authors:  Caterina Mammina; Daniela Maria Palma; Celestino Bonura; Aurora Aleo; Teresa Fasciana; Concetta Sodano; Maria Antonietta Saporito; Maria Stella Verde; Cinzia Calà; Andrea Neville Cracchiolo; Romano Tetamo
Journal:  BMC Res Notes       Date:  2012-07-20
View more
  20 in total

1.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

2.  Lysin LysMK34 of Acinetobacter baumannii Bacteriophage PMK34 Has a Turgor Pressure-Dependent Intrinsic Antibacterial Activity and Reverts Colistin Resistance.

Authors:  Karim Abdelkader; Diana Gutiérrez; Dennis Grimon; Patricia Ruas-Madiedo; Cédric Lood; Rob Lavigne; Amal Safaan; Ahmed S Khairalla; Yasser Gaber; Tarek Dishisha; Yves Briers
Journal:  Appl Environ Microbiol       Date:  2020-09-17       Impact factor: 4.792

3.  Clonal Dissemination of Clinical Isolates of Acinetobacter baumannii Carriers of 16S rRNA Methylase Genes in an Oncological Hospital in Recife, Brazil.

Authors:  Jussyêgles Niedja da Paz Pereira; Carlos Alberto das Neves de Andrade; Jailton Lobo da Costa Lima; Reginaldo Gonçalves de Lima Neto; Paulo Sérgio Ramos de Araújo; Maria Amélia Vieira Maciel
Journal:  Curr Microbiol       Date:  2019-10-26       Impact factor: 2.188

4.  Molecular characterization of carbapenemases of clinical Acinetobacter baumannii-calcoaceticus complex isolates from a University Hospital in Tunisia.

Authors:  Hadhemi Ben Cheikh; Sara Domingues; Eduarda Silveira; Yosr Kadri; Natasha Rosário; Maha Mastouri; Gabriela Jorge Da Silva
Journal:  3 Biotech       Date:  2018-06-27       Impact factor: 2.406

5.  Characterization of Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Hospitalized Patients in Palestine.

Authors:  Regeen Handal; Lulu Qunibi; Ibrahim Sahouri; Maha Juhari; Rula Dawodi; Hiyam Marzouqa; Musa Hindiyeh
Journal:  Int J Microbiol       Date:  2017-07-26

6.  The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital.

Authors:  Doaa Mohammad Ghaith; Mai Mahmoud Zafer; Mohamed Hamed Al-Agamy; Essam J Alyamani; Rayan Y Booq; Omar Almoazzamy
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-05-10       Impact factor: 3.944

7.  Prevalence of carbapenemases among high-level aminoglycoside-resistant Acinetobacter baumannii isolates in a university hospital in China.

Authors:  Yanhong Wang; Min Shen; Jingni Yang; Min Dai; Yaowen Chang; Chi Zhang; Guangxin Luan; Baodong Ling; Xu Jia
Journal:  Exp Ther Med       Date:  2016-10-20       Impact factor: 2.447

Review 8.  Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments.

Authors:  Emmanuel C Eze; Hafizah Y Chenia; Mohamed E El Zowalaty
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

9.  Landscape of Multidrug-Resistant Gram-Negative Infections in Egypt: Survey and Literature Review.

Authors:  Amani El-Kholy; Hadir A El-Mahallawy; Noha Elsharnouby; Mohamed Abdel Aziz; Ahmed Mohamed Helmy; Ramy Kotb
Journal:  Infect Drug Resist       Date:  2021-05-24       Impact factor: 4.003

10.  First identification of NDM-5 associated with OXA-181 in Escherichia coli from Egypt.

Authors:  Doaa Gamal; Marta Fernández-Martínez; Inas El-Defrawy; Alain A Ocampo-Sosa; Luis Martínez-Martínez
Journal:  Emerg Microbes Infect       Date:  2016-04-06       Impact factor: 7.163
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.